Maureen Ross

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

W. P. Peters, Maureen Ross, James J. Vredenburgh et al. · Journal of Clinical Oncology · 1993 · 502 citations

Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

WP Peters, GL Rosner, Maureen Ross et al. · Blood · 1993 · 253 citations · Full text

Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

WP Peters, GL Rosner, Maureen Ross et al. · Blood · 1993 · 223 citations · Full text

Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodes

Lawrence B. Marks, Edward C. Halperin, Leonard R. Prosnitz et al. · International Journal of Radiation Oncology*Biology*Physics · 1992 · 104 citations · Full text

Surgical Oncology, Breast Oncology, Radiation Therapy +10

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.

Elizabeth J. Shpall, Roy B. Jones, Robert C. Bast et al. · Journal of Clinical Oncology · 1991 · 89 citations

Breast Oncology, Immunology, Pathology +18